Canada Treats First Kids with Type 1 Diabetes Delay Drug
Two children in British Columbia just became the first in Canada to receive a medication that can delay type 1 diabetes by years. This marks a turning point for families who have spent decades waiting for treatments that change the disease course, not just manage symptoms.
For the first time in Canada, two children at BC Children's Hospital received a drug that can actually delay type 1 diabetes before they need insulin.
The medication, called Tzield, represents something the type 1 diabetes community has hoped for since diagnosis meant a lifetime of insulin dependence. Instead of waiting for the disease to progress, doctors can now intervene early and buy families precious time.
Clinical studies show Tzield delays insulin-dependent diabetes by about two years in eligible patients. For families facing this diagnosis, those two years mean fewer medical emergencies, more time to learn disease management, and a chance to help their child prepare mentally and emotionally.
The two young patients received the treatment through a compassionate care program from pharmaceutical company Sanofi. While a small number of Canadian adults have already received Tzield since Health Canada approved it in 2025, extending access to children marks a meaningful step forward.
In the United States, the FDA recently approved Tzield for children as young as one year old. Canada currently approves it for ages eight and up, though access remains limited.
The Ripple Effect
This breakthrough could reshape how we think about type 1 diabetes entirely. The key lies in early screening that catches the disease before symptoms appear.
Families with a type 1 diabetes history can access free screening through programs like TrialNet and FEDERATE-Can in Quebec. But since 85% of new cases have no family history, broader screening programs like UncoverT1D are working to identify more at-risk individuals.
The challenge now is access. Canada's Drug Agency recommended against reimbursing Tzield in January, meaning most families must pay out of pocket or rely on compassionate care programs. Breakthrough T1D Canada continues advocating for better coverage and screening access.
Early detection paired with disease-modifying treatments represents a fundamental shift from managing type 1 diabetes to potentially changing its trajectory. What began with two children in British Columbia could eventually help thousands of Canadian families catch this disease before it takes hold.
Every child who gains two more years without insulin injections is two more years of childhood preserved.
More Images
Based on reporting by Google News - Canada Breakthrough
This story was written by BrightWire based on verified news reports.
Spread the positivity!
Share this good news with someone who needs it
